-
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adultsPfizer Inc (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sB2011/8/1
-
SFDA issues notice on relevant issues on administrative licensing of health foodIn order to standardize and strengthen the management of health food administrative licensing, the State Food and Drug Administration (SFDA) recently issued a notice on relevant issues on the administ2011/7/29
-
SFDA to intensify supervision over accepting pharmaceutical contract manufacturing assignments from overseas pharmaceutical companiesThe State Food and Drug Administration (SFDA) issued a notice on July 22, 2011, which specifies relevant requirements on intensifying supervision over accepting pharmaceutical contract manufacturing a2011/7/29
-
Merck secures worldwide rights to vernakalant i.v.Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Astellas US LLC ("Astellas"), the U.S. subsidiary of Astellas Pharma Inc. (Tokyo:4503) today announced that they have entered i2011/7/28
-
High-dose vitamin D reduces musculoskeletal pain in breast cancer patientsHigh-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.2011/7/28
-
Surge of generics will trigger drop in drug pricesWith a number of the world's best-selling drugs soon to go "off patent," patients and insurers will see a reduction in prescription drug costs.With a number of the world's best-selling drugs soon to go "off patent," patients and insurers will see a reduction in prescription drug costs. CBS/AP: Prescription Drug Prices Set To Fall As Paten2011/7/28
-
FDA Notifies Pharmaceutical Companies that Studies Conducted by Cetero Research May Require ReevaluationThe FDA is notifying pharmaceutical companies that bioanalytical studies conducted by Cetero Research, Houston, Texas (Cetero) between April 2005 and June 2010 in support of marketing applications may2011/7/27
-
VeganZyme supplement may aid in reducing digestive discomfort and symptomsEvery year the American public spends billions of dollars on food and beverages that are toxic to the body and devoid of natural enzymes. These may include processed, microwaved or cooked food, meat,2011/7/27
-
SFDA issues Opinions on Improving Cosmetic Evaluation and Approval MechanismIn order to strengthen the management of cosmetic evaluation and approval, improve the evaluation and approval mechanism, standardize the evaluation and approval conducts and define the evaluation and2011/7/26
-
GlaxoSmithKline Flu Jab Linked to Sleep DisorderGlaxoSmithKline swine flu vaccine Pandemrix has been linked to narcolepsy in young people and should be used as a last line of protection, the European Medicines Agency has said. The agency recomme2011/7/26